49 completed, 2 withdrawn, 1 active not recruiting, 1 recruiting. 54 Phase 1, 7 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 54 | Completed 49, Withdrawn 2, Active not recruiting 1, Recruiting 1, Unknown 1 |
| Phase 2 | 7 | Completed 6, Recruiting 1 |
Follow Contraception: new trials by email Literature Review of Contraception trials Research Report on Contraception
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Drospirenone Only Pills: A Pre- and Post-Bariatric Surgery Study Drospirenone - Contraception | Phase 1 / Phase 2 | Recruiting | Chulalongkorn University | 16 | 2024-04-18 | 2026-03-19 |
| Casea S Contraceptive Implants (Casea S) Trial 22.2 mg Etonogestrel (ENG), 44.4 mg Etonogestrel (ENG) - Contraception | Phase 1 | Active not recruiting | FHI 360 | 20 | 2023-12-13 | 2026-04-08 |
| Comparative Bioavailability Study of Ethinyl Estradiol/Etonogestrel Vaginal Ring EVE119 vaginal ring, Nuvaring vaginal ring - Healthy Women, Female | Phase 1 | Completed | Evestra Inc. | 36 | 2023-07-29 | 2024-06-24 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LINO-1713 in Healthy Korean Female Subjects LINO-1713 1 tablet, LINO-1713 once a day for 24 days - Contraception | Phase 1 | Completed | Hyundai Pharm | 20 | 2022-01-11 | 2023-01-11 |
| A Study to Evaluate the Pharmacokinetics (PK) of Medroxyprogesterone Acetate Following an Injection of TV-46046 in Healthy Women of Reproductive Age TV-46046, Depo-subQ Provera - Contraception | Phase 1 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 60 | 2020-12-14 | 2024-02-26 |
| The Effects of Annovera™ and Tampon Co-Usage on the Pharmacokinetics of Segesterone Acetate and Ethinyl Estradiol Segesterone Acetate and Ethinyl Estradiol, Tampon - Contraception | Phase 1 | Completed | TherapeuticsMD | 21 | 2020-03-06 | 2021-10-29 |
| Annovera™ Drug-Drug Interaction Study Segesterone Acetate and Ethinyl Estradiol, Rifampin, Itraconazole - Women, Contraception | Phase 1 | Completed | TherapeuticsMD | 67 | 2020-02-12 | 2021-01-29 |
| A Study to Evaluate Injection Pain and Local Tolerability Following Subcutaneous (SC) Administration of TV-46046 TV-46046, Depo-subQ 104, TV-46046 Placebo - Contraception | Phase 1 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 27 | 2019-01-15 | 2022-01-26 |
| Antepartum Etonogestrel Contraceptive Implant Insertion at Term Etonogestrel 68Mg Implant - Contraception | Phase 1 | Withdrawn | University of Colorado, Denver | 2019-01-01 | 2019-04-17 | |
| PK Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel VR: 200 mg DPV + 320 mg LNG - Healthy, Contraception | Phase 1 | Completed | International Partnership for Microbicides, Inc. | 25 | 2018-07-17 | 2019-10-09 |
| Estetrol (E4)/Drospirenone (DRSP) Drug-drug Interaction (DDI) Study E4/DRSP, VAL - Contraception | Phase 1 | Completed | Estetra | 24 | 2018-04-12 | 2018-12-14 |
| On Demand Contraception: Ulipristal Acetate Plus a COX-2 Inhibitor at Peak Fertility Ulipristal Acetate 30 MG Oral Tablet - Contraception | Phase 1 | Completed | Stanford University | 12 | 2018-03-15 | 2019-06-25 |
| The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users Topiramate - Migraine, Migraine;Menstrual | Phase 1 | Completed | University of Colorado, Denver | 48 | 2018-03-15 | 2022-07-13 |
| A proof-of Concept, Randomized 3-month Study to Evaluate the Effects of Three Contraceptive Intrauterine Systems Delivering Copper and a Daily Dose of 5, 20 or 40 μg of Ulipristal Acetate (UPA) Ulipristal Acetate IUS delivering Cu and 5μg, Ulipristal Acetate IUS delivering Cu and 20μg, Ulipristal Acetate IUS delivering Cu and 40μg - Contraception | Phase 1 | Unknown | Population Council | 30 | 2017-05-01 | 2017-08-15 |
| Comparative Bioavailability of Two Injectable Suspension Formulations of Medroxyprogesterone Acetate+Estradiol Cypionate Test formulation, Reference formulation - Contraception | Phase 1 | Completed | Galeno Desenvolvimento de Pesquisas Clínicas | 24 | 2017-03-31 | 2018-02-23 |
| Safety, Tolerability and Pharmacokinetics of Estetrol (E4) After Single and Multiple Oral Doses in Healthy Female Volunteers 5 mg E4 single-dose, 15 mg E4 single-dose, 45 mg E4 single-dose - Contraception, Menopause | Phase 1 | Completed | Estetra | 31 | 2017-01-31 | 2017-09-08 |
| Compare Daily Ulipristal Acetate and Combined Oral Contraceptive Effects on Breast Epithelial Cell Proliferation Ulipristal Acetate, Combined Oral Contraceptive Pill - Contraception | Phase 1 | Completed | Columbia University | 29 | 2016-12-16 | 2020-02-07 |
| Lower Dose Depo Provera® Contraceptive Injection Depo-Provera CI, Depo-subQ 104 - Contraception | Phase 1 | Completed | FHI 360 | 60 | 2016-12-02 | 2018-06-14 |
| Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle TV-46046 - 400 mg/mL, TV-46046 - 200 mg/mL - Pregnancy, Contraception | Phase 1 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 12 | 2016-10-26 | 2024-02-12 |
| "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study" 15 mg E4/3 mg DRSP, 30 mcg EE/150 mcg LNG, 20 mcg EE/3 mg DRSP - Contraception, Liver Metabolism | Phase 1 / Phase 2 | Completed | Estetra | 101 | 2016-09-01 | 2018-02-05 |
Showing 20 of 54. Sign in to see all of them.
Hypogonadism (2) · Breast Neoplasms (1) · Contraception Behavior (1) · HIV Infections (1) · Migraine Disorders (1) · Obesity (1)
Endocrine System Diseases (2) · Gonadal Disorders (2) · Behavior (1) · Blood-Borne Infections (1) · Body Weight (1) · Brain Diseases (1) · Breast Diseases (1) · Central Nervous System Diseases (1) · Communicable Diseases (1) · Genital Diseases (1) · Headache Disorders (1) · Headache Disorders, Primary (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infections (1)
Medroxyprogesterone Acetate (6) · Testosterone (6) · drospirenone (6) · acyline (5) · Estetrol (4) · Ethinyl Estradiol (4) · Levonorgestrel (4) · levomefolate calcium (4) · Folic Acid (3) · drospirenone and ethinyl estradiol combination (3) · Ethinyl Estradiol-Norgestrel Combination (2) · Meloxicam (2) · N,N-dimethyl-4-anisidine (2) · etonogestrel (2) · norelgestromin (2)
Bayer (8) · University of Washington (7) · Estetra (6) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (5) · CONRAD (3) · FHI 360 (3) · Teva Branded Pharmaceutical Products R&D, Inc. (3) · University of Colorado, Denver (3) · Premier Research (2) · TherapeuticsMD (2) · Chulalongkorn University (1) · Columbia University (1) · Evestra Inc. (1) · Galeno Desenvolvimento de Pesquisas Clínicas (1) · Hyundai Pharm (1)
United States (23) · Dominican Republic (8) · Germany (4) · Canada (3) · Netherlands (3) · Brazil (2) · Chile (2) · Mexico (2) · United Kingdom (2) · Bulgaria (1) · Finland (1) · South Korea (1) · Sweden (1) · Thailand (1)
Christina Wang, MD (2) · John K Amory (2) · Sebastian Mirkin, MD (2) · Vera Halpern, MD (2) · William J Bremner, MD, PhD (2) · Aaron Lazorwitz, MD (1) · Carolyn Westhoff, MD (1) · Chris Mauck, MD (1) · Christine Klipping (1) · Christine Mauck (1) · David F Archer, MD (1)
PMID 17494097, PMID 20378927, PMID 10560680, PMID 11245554, PMID 11433905, PMID 12841897, PMID 16352669, PMID 16882745, PMID 16940442, PMID 17303493, PMID 17510436, PMID 18046048, PMID 19366848, PMID 19461456, PMID 22067789, PMID 22909145, PMID 23265980, PMID 23610531, PMID 2449395, PMID 24777591, PMID 26232513, PMID 27467196, PMID 28433989, PMID 29634911, PMID 29953547, PMID 30347490, PMID 31107913, PMID 31442441, PMID 31493139, PMID 31758920, PMID 32202076, PMID 32312141, PMID 33008401, PMID 33485608, PMID 33547015, PMID 3450848, PMID 35015210, PMID 35470225, PMID 35594123, PMID 36103980, PMID 36316023, PMID 37544572, PMID 37823034, PMID 39808648, PMID 41291952, PMID 7068318, PMID 7500749, PMID 7500750, PMID 9673838
2016 (3), U54HD042454 (3), 2005 (2), 2009 (2), K23HD045386 (2), 2014 (1), 2015 (1), 2017 (1), 5UM1AI068633 (1)